Allelic Exclusion and Peripheral Reconstitution by TCR Transgenic T Cells Arising From Transduced Human Hematopoietic Stem/Progenitor Cells by Giannoni, Francesca et al.
C
NSG NSG-A2
BM
PB
0.51%
24.85%
0.16%
76.95%
0.51%
0.16%
B
Lung
Spleen
Liver
NSG-A2NSG
D
Supplemental Figure 1 
NOD - SCID(X*X*)(0/0) NOD - SCID(X*Y)(A*0201/A*0201) 
(X*X)(A*0201/0) (X*Y)(A*0201/0) 
(X*Y)(A*0201/0) (X*X*)(0/0) 
(X*Y)(0/0) (X*X*)(A*0201/0) (X*X*)(0/0) (X*Y)(A*0201/0) 
(X*X*)(A*0201/0) (X*Y)(A*0201/0) 
(X*X*)(0/0) (X*X*)(A*0201/A*0201) (X*X)(A*0201/0) 
(X*Y)(0/0) (X*Y)(A*0201/0) (X*Y)(A*0201/A*0201) 
A 
P1 
F1 
F2 
F3 
Supplemental Figure 2 
  
1 
 
SUPPLEMENTAL METHODS 
Quantitative PCR for Vector Copy Number (VCN): Proviral vector copy numbers per cell 
(VCN) were assayed using primers that target the HIV-1 “psi” packaging region of the CCLc-
MND-F5 lentivirus: (forward)-AACTGAAAGCGAAAGGGAAAC; (reverse)-
CGCACCCATCTCTCTCCTTCT) and (probe)-AGCTCTCTCGACGCAGGACTCGGC with 5’ 
6-carboxyfluorescein (FAM) and 3’ 6-carboxy-tetramethyl-rhodamine (TAMRA) labels.  
Samples assayed for vector proviral VCN content were compared to a known two copy of 
vector per cell standard and the data analyzed with the Applied Biosystems 7500 Software v. 
2.0.4 (Life Technologies Corp., Carlsbad, CA).   
 
Quantitative PCR for Human HLA A*0201  Transgene in Mice: To evaluate mice for the 
human HLA A*0201 transgene during derivation of the NSG-A2 mice, murine DNA samples 
were screened for the presence of the human HLA A*0201 allele using the HLA A2 primers 
(forward)-TCCTCGTCCCCAGGCTCT; (reverse)-TGTCGTCCACGTAGCCCACT) and 
(probe)-ACGGATGTGAAGAAAT with 5’ FAM and 3’ minor groove binder non-fluorescent 
quencher (MGBNFQ) labels. Primers to the endogenous murine DMa gene (forward)-
CATCCATCTCAGCCGTCGAT; (reverse)-CAAAGGGTTCCGGTGTGAAGT and (probe)-
6FAM-TTCCAGGCTTTCTCTTATT-MGBNFQ were used as an internal control. Control 
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samples included DNA from A2 homozygous mice, DNA from obligate A2 hemizygous mice 
and DNA from normal mice. Reactions were run in parallel and not multi-plexed. 
     Data were analyzed with the 7500 Software v. 2.0.4 (Life Technologies Corp.) to 
determine cycle threshold (Ct) for each replicate. The change in Ct value compared to the 
DMa gene control was calculated as an average of the replicates for A2 subtracted from the 
average of replicates for DMa. The delta Ct values were graphed and gauged visually to 
determine the appropriate cut off for homozygosity (Supplemental Figure 1).   
 
Quantitative PCR for Human A2 Haplotype: Human DNA samples that were typed for the 
presence of HLA A2 used the HLA A2 primers described above.  Primers to the endogenous 
human Syndecan-4 (SDC4) gene (forward)-CAGGGTCTGGGAGCCAAGT; (reverse)-
GCACAGTGCTGGACATTGACA and (probe)-VIC-
CCCACCGAACCCAAGAAACTAGAGGAGAAT-TAMRA were used as an internal control. 
Control samples included DNA from a healthy A2 positive donor, DNA from A2 negative 
K562 cells and murine DNA from A2 positive and negative mice. Reactions were run in 
parallel and not multi-plexed.  Data were analyzed and scored depending upon whether 
amplification of the sample with the A2 primer set was observed. A2 positive, SDC4 positive 
samples were scored as “A2 positive.” A2 negative, SDC4 positive samples were scored as 
“A2 negative.” 
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SUPPLEMENTAL LEGENDS FOR SUPPLEMENTAL FIGURES 
Supplemental Figure 1. Generation of HLA A*0201–NSG (NSG-A2) mice.  A. Breeding 
schema for the derivation of the NSG-A2 strain.  The matching colored boxes denote mice of 
the same genotype. Briefly, parent (P) NSG females (indicated as NOD-SCID (X*X*)(00) 
where X* is the X chromosome with the IL2Rgamma gene disrupted -red) were crossed with 
NOD-SCID-HLA*A0201 males (indicated as NOD-SCID (XY)(A*0201/A*0201 – black). Male 
offspring in the F1 generation (X*Y)(A*0201/0 - blue) were backcrossed with NSG females 
(red) to yield the F2 generation. IL2Rgamma null, A2  hemizygous females (green) and 
IL2Rgamma null, A2 hemizygous males (yellow) were identified by quantitative PCR for the 
human HLA*A0201 allele (see below, B) and crossed to yield the F3 generation. Male and 
female F3 offspring that were both IL2Rgamma null and A2 homozygous were then cross-
bred for several generations to create the target strain, NSG-A2.   
B. Represenative results from the PCR-based genotyping assay that distinguishes between 
HLA A*0201  (A2) hemizygous and homozygous mice. Mice 1-2 are known A2 homozygotes 
(avg. deltaCt = -1.82), mice 3-6 are known A2 hemizygotes (avg. deltaCt = -0.57) and mice 
7-13 (avg. deltaCt = -1.72) are test mice of an unknown genotype. The difference in 
deltaCt between A2 homozygous and hemizygous mice was -1.17, which represents 
the difference of one amplification cycle.   
C. Flow cytometric analysis of cells stained with an anti-human HLA-A2 antibody. The 
panels on the left are from the bone marrow (BM - top) and peripheral blood (PB - bottom) 
of a control NSG mouse while the panels on the right are from the BM and PB of an NSG-A2 
mouse.   
D. Immunohistochemical analysis of tissues for human HLA A2 expression. The sections 
were  stained with anti-hu HLA A2 FITC followed by an anti-FITC secondary antibody 
conjugated to horseradish peroxidase with diaminobenzidine substrate yielding brown color 
in A2-positive samples. The panels on the left are from the lung (top) and spleen (bottom) of 
an NSG control mouse while the panels on the right are from the lung and spleen of an 
NSG-A2 mouse.  
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Supplemental Figure 2. Engraftment of NSG-A2 mice was determined by 
multichromatic flow cytometry analysis of peripheral blood (obtained 8 weeks after 
transplant. Human engraftment was determined as %hCD45/%totalCD45 (human and 
murine) in the lymphocyte gate. Subsequent populations were defined as the 
percentage of the hCD45+ cells that were: myeloid (hCD33+), monocytes/macrophages 
(hCD33+/hCD14+), B-cells (hCD19+), T-cells (hCD3+). F5 TCR+ T-cells were 
determined as the percentage of hCD3+ T-cells binding to HLA-2.1 tetramers loaded 
with the MART-1 peptide (ELAGIGILTV).  
 
 
 
